Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide pilot study in acute ischemic stroke
ACTRN12609000983202Phase 2Not yet recruiting
- Sponsor
- Monash University Eastern Clinical Research Unit
- Start
- Dec 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of exenatide in ischemic stroke (2 arms), sponsored by Monash University Eastern Clinical Research Unit. Primary endpoint: Change in inflammatory and endothelial markers. Planned start Dec 2009; status: not yet recruiting.
02
Drugs
exenatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ACTRN12609000983202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000983202.